FindTrial
Sign In

A web-based survey on itching in patients with seasonal allergic conjunctivitis in 2023

A web-based survey on itching in patients with seasonal allergic conjunctivitis in 2023 - A web-based survey on itching in patients with seasonal allergic conjunctivitis in 2023

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000050732
Enrollment
1000
Registered
2023-03-31
Start date
2023-03-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seasonal allergic conjunctivitis

Interventions

None listed

Sponsors

Santen Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects diagnosed with seasonal allergic conjunctivitis by an ophthalmologist and prescribed anti histamine eye drops after December 2022. Subjects with itchy eyes associated with seasonal allergic conjunctivitis in at least one eye after December 2022.

Exclusion criteria

Exclusion criteria: Medical professionals (doctors, pharmacists, nurses, etc.) Subjects engaged in pharmaceuticals and medical devices industry Subjects engaged in pharmaceuticals distributor Subjects engaged in information provision services, research services, and advertising Subjects with severe allergic conjunctival disease (vernal keratoconjunctivitis , atopic keratoconjunctivitis)

Design outcomes

Primary

MeasureTime frame
The situation of eye itch The relationship between eye itch and eye drop behavior—

Countries

Japan

Contacts

Public ContactHirotsugu Kishimoto

Santen Pharmaceutical Co., Ltd. Japan Medical Affairs Group

clinical@santen.co.jp06-4802-9337

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026